Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Truvada

Truvada

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Truvada

20 trials tracked of Truvada: 11 in phase 3 or 4 and 3 with published results. The most-cited published study has 35 citations.

20Trials tracked
11Phase 3 & 4
0Recruiting
3With published results
Phase distribution
Phase 4 8 Phase 3 3 Phase 2 6 Phase 1 2 Other / NA 1
  1. Phase 4 Feasibility and Acceptability of Digital Pills to Monitor PrEP Adherence in MSM With Substance Use Completed · 35 cited
  2. Phase 4 Uptake and Adherence to Daily Oral PrEP as a Primary Prevention Strategy for Young African Women: A Vanguard Study Completed · 10 cited
  3. Phase 3 Development of Ingestible Biosensors to Enhance PrEP Adherence in Substance Users (PrEPSteps) Completed
  4. Phase 4 Peripheral Body Fat Distribution After Switching Zidovudine and Lamivudine to Truvada Completed
  5. Phase 4 PrEP, Lube, and the Rectal Mucosa in MSM at Risk of HIV Completed
  6. Phase 4 REMEMBER: Reducing Early Mortality & Morbidity by Empiric Tuberculosis (TB) Treatment Completed
Show 14 more trials
  1. Phase 4 TOTEM: Switch From Other Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to Once Daily Truvada Completed
  2. Phase 4 Switch From Combivir or Trizivir to Truvada - Mitochondrial Effects Completed
  3. Phase 4 Truvada Plus Raltegravir for Nonoccupational Post-exposure Prophylaxis (nPEP) Completed
  4. Phase 3 Evaluation of the Safety and Efficacy of Reformulated Raltegravir (MK-0518) 1200 mg Once Daily in Combination With TRUVADA™ in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-Naive Participants (MK-0518-292) Completed
  5. Phase 3 FEM-PrEP (Truvada®): Study to Assess the Role of Truvada® in Preventing HIV Acquisition in Women Completed
  6. Phase 2 Contingency Management for Methamphetamine Abstinence and HIV Post-Exposure Prophylaxis in Men Who Have Sex With Men Completed
  7. Phase 2 Biobehavioral Interventions for HIV-negative, Stimulant Using Men Who Have Sex With Men Completed
  8. Phase 2 Pre-Exposure Prophylaxis (PrEP) Adherence Monitoring Using Dried Blood Spots Completed
  9. Phase 2 A Dose-Ranging Study to Compare Doravirine (MK-1439) Plus TRUVADA® Versus Efavirenz Plus TRUVADA® in Human Immunodeficiency Virus (HIV)-1 Infected Participants (MK-1439-007) Completed
  10. Phase 2 Evaluating Once Daily Etravirine in Treatment-Naive Adults With HIV Infection Completed
  11. Phase 2 Acceptability, Safety, and Use of Daily Truvada Pre-Exposure Prophylaxis in Adolescents Completed
  12. Phase 1 The Maraviroc Darunavir/Ritonavir Once Daily Pharmacokinetic Study Completed
  13. Phase 1 Body Compartment PK for New HIV Pre-exposure Prophylaxis Modalities Completed
  14. N/A Effects of the Anti-HIV Pill Truvada on Gene Transcription in the Gastrointestinal Tract of HIV-uninfected Individuals Completed

Showing the 20 most-cited and recently-updated of 20 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.